Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients

G. Visani, F. Ferrara, F. Di Raimondo, F. Loscocco, G. Sparaventi, S. Paolini, F. Fuligni, A. Gazzola, M. Rossi, M. A. Laginestra, M. R. Caraci, C. Riccardi, M. Rocchi, A. Visani, S. A. Pileri, P. P. Piccaluga, A. Isidori

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)967-970
Number of pages4
Issue number4
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this